Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases

Kent W. Christopherson, Antoinette F. Hood, Jeffrey B. Travers, Heather Ramsey, Robert A. Hromas

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The signals that mediate T-cell infiltration during T-cell autoimmune diseases are poorly understood. The chemokine CCL21 (originally isolated by us and others as Exodus-2/6Ckine/SLC/TCA4) is highly potent and highly specific for stimulating T-cell migration. However, it is thought to be expressed only in secondary lymphoid organs, directing naive T cells to areas of antigen presentation. It is not thought to play a role in T-cell effector function during a normal immune response. In this study we tested the expression of T-cell chemokines and their receptors during T-cell autoimmune infiltrative skin diseases. By using immunohistology it was found that the expression of CCL21 but not CCL19 or 20 was highly induced in endothelial cells of T-cell autoimmune diseases. The receptor for CCL21, CCR7, was also found to be highly expressed on the infiltrating T cells, most of which expressed the memory CD45Ro phenotype. These data imply that the usual loss of CCL21 responsiveness in the normal development of memory T-cell effector function does not hold for autoimmune skin diseases.

Original languageEnglish (US)
Pages (from-to)801-806
Number of pages6
Issue number3
StatePublished - Feb 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases'. Together they form a unique fingerprint.

Cite this